These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 36560633)

  • 21. Airborne virus shedding of the alpha, delta, omicron SARS-CoV-2 variants and influenza virus in hospitalized patients.
    Ong DSY; de Man P; Verhagen T; Doejaaren G; Dallinga MA; Alibux E; Janssen ML; Wils EJ
    J Med Virol; 2023 Apr; 95(4):e28748. PubMed ID: 37185846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of SARS-CoV-2 isolates, namely the Wuhan strain, Delta variant, and Omicron variant, identifies differential immune profiles.
    Shahbaz S; Bozorgmehr N; Lu J; Osman M; Sligl W; Tyrrell DL; Elahi S
    Microbiol Spectr; 2023 Sep; 11(5):e0125623. PubMed ID: 37676005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term prognosis at 1.5 years after infection with wild-type strain of SARS-CoV-2 and Alpha, Delta, as well as Omicron variants.
    Agergaard J; Gunst JD; Schiøttz-Christensen B; Østergaard L; Wejse C
    Int J Infect Dis; 2023 Dec; 137():126-133. PubMed ID: 37907167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SARS CoV-2 reinfection rate is higher in the Omicron variant than in the Alpha and Delta variants.
    Özüdoğru O; Bahçe YG; Acer Ö
    Ir J Med Sci; 2023 Apr; 192(2):751-756. PubMed ID: 35711013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission.
    Shrestha LB; Foster C; Rawlinson W; Tedla N; Bull RA
    Rev Med Virol; 2022 Sep; 32(5):e2381. PubMed ID: 35856385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of Cardiopulmonary Exercise Testing to Evaluate Long COVID-19 Symptoms in Adults: A Systematic Review and Meta-analysis.
    Durstenfeld MS; Sun K; Tahir P; Peluso MJ; Deeks SG; Aras MA; Grandis DJ; Long CS; Beatty A; Hsue PY
    JAMA Netw Open; 2022 Oct; 5(10):e2236057. PubMed ID: 36223120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of post-COVID symptoms of the SARS-CoV-2 Delta and Omicron variants in children: a prospective study.
    Yildirim Arslan S; Avcu G; Sahbudak Bal Z; Arslan A; Ozkinay FF; Kurugol Z
    Eur J Pediatr; 2023 Oct; 182(10):4565-4571. PubMed ID: 37526704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relative prevalence of the Omicron variant within SARS-CoV-2 infected cohorts in different countries: A systematic review.
    Sarkar A; Omar S; Alshareef A; Fanous K; Sarker S; Alroobi H; Zamir F; Yousef M; Zakaria D
    Hum Vaccin Immunother; 2023 Dec; 19(1):2212568. PubMed ID: 37254497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: Pooled analysis of two population-based cohorts.
    Ballouz T; Menges D; Kaufmann M; Amati R; Frei A; von Wyl V; Fehr JS; Albanese E; Puhan MA
    PLoS One; 2023; 18(2):e0281429. PubMed ID: 36812215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibodies in COVID-19 survivors with post-COVID symptoms: a systematic review.
    Notarte KI; Carandang THDC; Velasco JV; Pastrana A; Ver AT; Manalo GN; Ng JA; Grecia S; Lippi G; Henry BM; Fernández-de-Las-Peñas C
    Front Immunol; 2024; 15():1428645. PubMed ID: 39035011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of Musculoskeletal Post-COVID Pain in Hospitalized COVID-19 Survivors Depending on Infection with the Historical, Alpha or Delta SARS-CoV-2 Variant.
    Fernández-de-Las-Peñas C; Cancela-Cilleruelo I; Moro-López-Menchero P; Rodríguez-Jiménez J; Gómez-Mayordomo V; Torres-Macho J; Pellicer-Valero OJ; Martín-Guerrero JD; Hernández-Barrera V; Arendt-Nielsen L
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-covid medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants.
    Magnusson K; Kristoffersen DT; Dell'Isola A; Kiadaliri A; Turkiewicz A; Runhaar J; Bierma-Zeinstra S; Englund M; Magnus PM; Kinge JM
    Nat Commun; 2022 Nov; 13(1):7363. PubMed ID: 36450749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased Sensitivity of Rapid Antigen Test Is Associated with a Lower Viral Load of Omicron than Delta SARS-CoV-2 Variant.
    Cocherie T; Bastide M; Sakhi S; Zafilaza K; Flandre P; Leducq V; Jary A; Burrel S; Louet M; Calvez V; Marcelin AG; Marot S
    Microbiol Spectr; 2022 Oct; 10(5):e0192222. PubMed ID: 36125269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: A meta-analysis of the current literature.
    Fernández-de-Las-Peñas C; Navarro-Santana M; Gómez-Mayordomo V; Cuadrado ML; García-Azorín D; Arendt-Nielsen L; Plaza-Manzano G
    Eur J Neurol; 2021 Nov; 28(11):3820-3825. PubMed ID: 34327787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Omicron variant BA.1.1 presents a lower pathogenicity than B.1 D614G and Delta variants in a feline model of SARS-CoV-2 infection.
    Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
    bioRxiv; 2022 Jun; ():. PubMed ID: 35734088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutralizing Activity of SARS-CoV-2 Antibodies in Patients with COVID-19 and Vaccinated Individuals.
    Vilibic-Cavlek T; Stevanovic V; Kovac S; Borko E; Bogdanic M; Miletic G; Hruskar Z; Ferenc T; Coric I; Vujica Ferenc M; Milasincic L; Antolasic L; Barbic L
    Antibodies (Basel); 2023 Sep; 12(4):. PubMed ID: 37873858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effects of SARS-CoV-2 infection in hospitalized children: findings from an Italian single-center study.
    Calcaterra V; Tagi VM; D'Auria E; Lai A; Zanelli S; Montanari C; Biganzoli EM; Marano G; Borghi E; Massa V; Riva A; Zuccotti G
    Ital J Pediatr; 2024 Feb; 50(1):27. PubMed ID: 38355648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis.
    Relan P; Motaze NV; Kothari K; Askie L; Le Polain O; Van Kerkhove MD; Diaz J; Tirupakuzhi Vijayaraghavan BK
    BMJ Glob Health; 2023 Jul; 8(7):. PubMed ID: 37419502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
    Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
    PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody response against SARS-CoV-2 variants of concern in children infected with pre-Omicron variants: An observational cohort study.
    Seery V; Raiden S; Russo C; Borda M; Herrera L; Uranga M; Varese A; Marcó Del Pont M; Chirino C; Erramuspe C; Álvarez LS; Lenoir M; Morales LD; Davenport C; Alarcón Flores A; Huespe Auchter S; Ruiz Y; Monsalvo L; Sastoque L; Gavazzi M; Mazzitelli I; Di Diego F; Longueira Y; Mazzitelli B; Sananez I; De Carli N; Biglione MM; Gómez Penedo JM; Ceballos A; Laufer N; Ferrero F; Geffner J; Arruvito L
    EBioMedicine; 2022 Sep; 83():104230. PubMed ID: 35988465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.